TrialBritish journal of haematology2021

Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma.

Sridurga Mithraprabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.